Murphy, S. A., Cannon, C. P., Blazing, M. A., Giugliano, R. P., Tershakovec, A. M., & Braunwald, E. (2016). Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? J Am Coll Cardiol, 67(25), 3025–3026. https://doi.org/10.1016/j.jacc.2016.03.580

Murphy, Sabina A., Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano, Andrew M. Tershakovec, and Eugene Braunwald. “Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?” J Am Coll Cardiol 67, no. 25 (June 28, 2016): 3025–26. https://doi.org/10.1016/j.jacc.2016.03.580.

Murphy SA, Cannon CP, Blazing MA, Giugliano RP, Tershakovec AM, Braunwald E. Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? J Am Coll Cardiol. 2016 Jun 28;67(25):3025–6.

Murphy, Sabina A., et al. “Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?” J Am Coll Cardiol, vol. 67, no. 25, June 2016, pp. 3025–26. Pubmed, doi:10.1016/j.jacc.2016.03.580.

Murphy SA, Cannon CP, Blazing MA, Giugliano RP, Tershakovec AM, Braunwald E. Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? J Am Coll Cardiol. 2016 Jun 28;67(25):3025–3026.